EUVIMEDEUVIMED entdecken
Crossref

210 | REAL‐WORLD COMPARATIVE EFFECTIVENESS OF FIRST‐LINE BRUTON TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

R. Jacobs, X. Wang, Q. Fu, D. Yuan, D. van Beuge, G. A. Maglinte, E. K. Seymour, M. Shadman

Hematological Oncology · 2025-06 · 43 (S3)

DOI: 10.1002/hon.70094_210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, online erschienen am 16.06.2025. Verfasst von R. Jacobs und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Jacobs, R., Wang, X., Fu, Q., Yuan, D., Beuge, D. V., Maglinte, G. A., Seymour, E. K., & Shadman, M. (2025). 210 | REAL‐WORLD COMPARATIVE EFFECTIVENESS OF FIRST‐LINE BRUTON TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Hematological Oncology, 43(S3). https://doi.org/10.1002/hon.70094_210

Vancouver

Jacobs R, Wang X, Fu Q, Yuan D, Beuge DV, Maglinte GA, et al. 210 | REAL‐WORLD COMPARATIVE EFFECTIVENESS OF FIRST‐LINE BRUTON TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Hematological Oncology. 2025;43(S3). doi:10.1002/hon.70094_210

BibTeX
@article{Jacobs2025,
  author = {Jacobs, R. and Wang, X. and Fu, Q. and Yuan, D. and Beuge, D. van and Maglinte, G. A. and Seymour, E. K. and Shadman, M.},
  title = {210 | REAL‐WORLD COMPARATIVE EFFECTIVENESS OF FIRST‐LINE BRUTON TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA},
  journal = {Hematological Oncology},
  year = {2025},
  volume = {43},
  number = {S3},
  doi = {10.1002/hon.70094_210}
}
Kostenlos starten →